Prosensa's Series C Round

Prosensa raised a round of funding on January 25, 2012.

Prosensa is a biotechnology company focused on the discovery, development and commercialization of RNA-modulating therapeutics. The company targets genetic disorders with a large unmet medical need, w…

Articles about Prosensa's Series C Round: